Table 4.
Multivariable Logistic Regression Analysis of Factors Associated with Colorectal Cancer Screening Adherence per US Preventive Services Task Force Guideline
| FOBT OR (95% CI) | CRC screening Adherence OR (95% CI) | |
|---|---|---|
| Site | ||
| Clinic 2 | 1.00 | 1.00 |
| Clinic 1 | 0.74 (0.46, 1.19) | 0.685 (0.46, 1.02) |
| Age | ||
| 50–64 | 1.00 | 1.00 |
| 65–75 | 0.90 (0.62, 1.29) | 1.10 (0.82, 1.48) |
| Gender | ||
| Male | 1.00 | 1.00 |
| Female | 1.75 (1.21, 2.52) | 1.56 (1.17, 2.09) |
| Insurance | ||
| None | 1.00 | 1.00 |
| Public | 1.99 (1.18, 3.37) | 3.02 (1.92, 4.76) |
| Private | 1.15 (0.60, 2.19) | 2.76 (1.63, 4.67) |
| (Public vs. Private) | 1.73 (1.08, 2.28) | 1.10 (0.77, 1.57) |
| Continuity Index | ||
| 1 Visit | 1.00 | 1.00 |
| Lower | 2.75 (1.19, 6.34) | 3.22 (1.70, 6.12) |
| Higher | 3.01 (1.27, 7.14) | 3.62 (1.86, 7.05) |
| (Higher vs. Lower) | 1.09 ( 0.74, 1.60) | 1.12 (0.82, 1.54) |
| Charlson-Deyo Comorbidity Index | ||
| 0 | 1.00 | 1.00 |
| 1 | 1.02 (0.70, 1.49) | 0.99 (0.72, 1.37) |
| ≥ 2 | 0.71 (0.36, 1.39) | 1.08 (0.65, 1.79) |
| Provider type and Language Concordance | ||
| None | 1.00 | 1.00 |
| MD Language Concordant | 2.85 (0.59, 13.65) | 4.39 (1.15, 16.73) |
| MD Language Non-concordant | 1.30 (0.28, 6.08) | 3.64 ( 0.98, 13.49) |
| Non-MD Language Concordant | 0.75 (0.16, 3.57) | 1.90 (0.51, 7.08) |
| Non-MD Language Non-concordant | 4.10 (0.87, 13.36) | 4.65 (1.23, 17.61) |
CRC = colorectal cancer; FOBT = fecal occult blood test; MD = physician